Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Assessor-blinded Randomized Parallel Group Multi-centre Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA Versus Gonal-f) in Women for Assisted Reproductive Treatment

NCT01121666 is registered in ClinicalTrials.gov with Finox AG as lead sponsor.

NCT NCT01121666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01121666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Assessor-blinded Randomized Parallel Group Multi-centre Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA Versus Gonal-f) in Women for Assisted Reproductive Treatment
Lead sponsor
Finox AG
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2010
Completion date
March 31, 2013
Enrollment
460 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

infertility